Yanmin Hu

Hub Metabolites Promote the Bioflocculant Production in a Biomass-Degrading Bacterium Pseudomonas boreopolis GO2

The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> in Clinical Settings.

The superposition effects of air pollution on government health expenditure in China— spatial evidence from GeoDetector

The emerging roles of neutrophil extracellular traps in wound healing

Mefloquine enhances the activity of colistin against antibiotic-resistant Enterobacterales in vitro and in an in vivo animal study

Zidovudine enhances activity of carbapenems against NDM-1-producing Enterobacteriaceae.

Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction.

Effect of Different Media on the Bactericidal Activity of Colistin and on the Synergistic Combination With Azidothymidine Against <i>mcr-1-</i>Positive Colistin-Resistant <i>Escherichia coli</i>.

The small quinolone derived compound HT61 enhances the effect of tobramycin against Pseudomonas aeruginosa in vitro and in vivo.

Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction

Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant <i>Enterobacteriaceae</i>.

Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals

Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.

Urinary bactericidal activity of colistin and azidothymidine combinations against mcr-1-positive colistin-resistant Escherichia coli.

Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces